samedan logo

 
 
spacer
home > ebr > spring 2003 > utility, inventiveness and patenting dna
PUBLICATIONS
European Biopharmaceutical Review

Utility, Inventiveness and Patenting DNA

In July 2002 a group of leading scientists and lawyers looked in detail at the sometimes vexed question of patents that relate to claims involving DNA and genetic technology in general. The Nuffield Council on Bioethics comprehensively reviewed the interaction of ethical issues, with both the law of patents and its practical impact upon research and development, in the discussion paper The Ethics of Patenting DNA (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Brian Cain, Solicitor with Richards Butler

Brian Cain is a solicitor currently practising with Richards Butler. Brian is the author of Legal Aspects of Gene Technology, a new book published by Sweet & Maxwell dealing with issues ranging from potential liabilities arising out of the release or marketing of GM products to protecting the intellectual property in GM technology.

He holds a Law degree from Bristol University and a degree in Biological Sciences from the University of London.

spacer
Brian Cain
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement